Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Shown
Thomas Shown
University of California, Davis
Urology
Prostate-specific antigen
Finasteride
Medicine
Prostate
3
Papers
304
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo ☆
1999
Urology
Claus G. Roehrborn
Peter Boyle
Donald Bergner
Todd Gray
Marc C. Gittelman
Thomas Shown
Arnold Melman
R. Bruce Bracken
Ralph W. deVere White
Alice Taylor
Daniel Wang
Joanne Waldstreicher
Show All
Source
Cite
Save
Citations (211)
Biologic Variability of Prostate-Specific Antigen and its Usefulness as a Marker for Prostate Cancer: Effects of Finasteride
1997
Urology
Joseph E. Oesterling
Johnny B. Roy
Arif H. Agha
Thomas Shown
Torben Krarup
Truls E. Bjerklund Johansen
Mikael Lagerkvist
Glenn J. Gormley
Mark A. Bach
Joanne Waldstreicher
Show All
Source
Cite
Save
Citations (52)
1